leisure time -WSS

leisure time

author：fashion 2025-09-27 23:00:34 - browse：392

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT wants to know your pick for a great summer read or listen

WSS

House transparency, PBM reform bill gains bipartisan support

A letter from the executive editor: The 2023 STATUS List

What affirmative action's end means to a medical student

How generative AI is inspiring dreams of a health data revolution

How Robert F. Kennedy Jr. distorted vaccine science

'Screen and refer' systems are hurting patients

explore

leisure time

explore

After affirmative action ruling, medical educators look to 'holistic review'

The wait for US passports is creating travel purgatory and snarling summer plans

Sports medicine is finally prioritizing gender equality

STAT wants to know your pick for a great summer read or listen

Wildfire smoke exposes gaps in outdoor worker protections

Crinetics acromegaly drug succeeds in late

Malaria cases in Florida and Texas: Here’s what you need to know

Stem cell treatment guidelines are released by FDA

Medicare proposal to cover medical devices draws a mixed reaction

The 10 drugs up first for Medicare price negotiation

focus

Security flaws in third

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The (many) problems with a new study criticizing cancer screening

Humana sues Biden admin over Medicare Advantage audit rule

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Skip the lead apron during X

explore

leisure time

knowledge

leisure time